Norfenicol solution recalled amid concerns over sterility
Norbrook Laboratories has issued a recall of Norfenicol 300 mg/ml solution for injection amid concerns about its sterility.
Norbrook Laboratories has issued a recall of Norfenicol 300 mg/ml solution for injection amid concerns about its sterility.
The recall affects batch no. 9054-91B Norfenicol 300 mg/ml solution for injection, expiry 31/01/2021
The Veterinary Medicines Directorate said: “We wish to make wholesalers and veterinary surgeons aware that Norbrook Laboratories has issued a recall of Norfenicol 300 mg/ml solution for injection (Vm 02000/4316) for all vial sizes below 250ml. This is a precautionary measure as some of them contain media which was not clear or transparent so sterility cannot be assured.
“Norbrook Laboratories Ltd is contacting wholesale dealers and veterinary surgeons to examine inventory immediately and quarantine products subject to this recall. Other batches of Norfenicol 300 mg/ml solution for injection are not impacted and may continue to be distributed.”
To obtain further information about the recall contact Ms Naomh Thompson +44 02830 264435 or email naomh.thompson@norbrook.co.uk
The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.
